Atlas Trials

Single Ascending Dose Study With Healthy Male Volunteers and Type II Diabetic Patients

Clinical trial NCT00886366 · TERMINATED

Trial details

NCT number
NCT00886366
Sponsor
AstraZeneca
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2009-04-01
Primary completion
2009-09-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.